Boston, MA -- (SBWIRE) -- 09/05/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (InvenSense Inc (NYSE:INVN), Capstone Turbine Corporation (NASDAQ:CPST), Halcon Resources Corp(NYSE:HK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
InvenSense Inc (NYSE:INVN) shares increased 1.41% to $18. Investment analysts at Needham & Company began coverage on shares of INVN in a note issued to investors on August 22. The firm set a “buy” rating and a $20.00 price target on the stock.
Additionally, the company on July 30 announced its first quarter fiscal year 2014 results. Net revenue for the first fiscal quarter of 2014 was $55.9 million, up from $39.2 million for the first fiscal quarter of 2013. Net income for the first fiscal quarter of 2014 was $10.3 million, up from $7.7 million for the first fiscal quarter of 2013. Diluted earnings per share for the first fiscal quarter of 2014 was $0.12, up from $0.09 for the first fiscal quarter of 2013.
Is INVN A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Capstone Turbine Corporation (NASDAQ:CPST) shares decreased 3.17% to $1.07. The company on August 8 announced its financial results for the first quarter of fiscal year 2014 ended June 30, 2013. Revenue for the first quarter of Fiscal 2014 was $24.4 million, compared to $35.4 million for the fourth quarter of Fiscal 2013, and $28.8 million for the first quarter of Fiscal 2013. The company’s net loss was $6.8 million, or $0.02 loss per share, for the first quarter of Fiscal 2014, versus net loss of $4.1 million, or $0.01 loss per share, for the fourth quarter of Fiscal 2013, and a net loss of $7.8 million, or $0.03 per share, for the first quarter of Fiscal 2013.
Is CPST A Good Buy After The Recent Price Movement? Find Out Here
Halcon Resources Corp(NYSE:HK) shares declined 0.42% to $4.72. The company announced that Floyd C. Wilson, Chairman and Chief Executive Officer, is scheduled to present at the Barclays CEO Energy-Power Conference in New York on Thursday, September 12, 2012 at 8:25 a.m. EDT (7:25 a.m. CDT).
Additionally, the company on August 8 announced that it has priced an underwritten public offering of 38,000,000 shares of its common stock at a price of $5.10 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 5,700,000 shares of common stock. The offering is expected to settle and close on August 13, 2013, subject to customary closing conditions.
How Should Investors Trade HK After The Recent Volatility? Get Free Report Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock fell 0.30% to $6.55. The company on August 28 announced the completion of a Phase 1b clinical trial for APD811, an investigational oral prostacyclin (IP) receptor agonist intended for the treatment of pulmonary arterial hypertension (PAH). The company plans to initiate a Phase 2 clinical trial for APD811 in the first quarter of 2014. This randomized, double-blind and placebo-controlled Phase 1b clinical trial evaluated the safety, tolerability and pharmacokinetics of multiple-ascending doses of APD811. Arena previously evaluated single-ascending doses of APD811 in a Phase 1a clinical trial.
How Should Investors Trade ARNA After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)